DHR:NYSE
Danaher Corp
$214.06
arrow_upward
+1.09%(+2.30) 1D
$214.06
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:02:30 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHR...
Open
$213.40
High
$216.06
Low
$211.98
Mkt. cap
150.48B
Avg. vol.
3.98M
Volume
3.92M
Dividend
0.75%
Quarterly dividend
$0.40
Ex-dividend date
Sep 30, 2026
P/E ratio
38.00
52-wk high
$242.80
52-wk low
$160.93
EPS
$5.63
Beta
0.77
Shares outstanding
702.99M
No. of employees
59K
Open
$213.40
High
$216.06
Low
$211.98
Mkt. cap
150.48B
Avg. vol.
3.98M
Volume
3.92M
Dividend
0.75%
Quarterly dividend
$0.40
Ex-dividend date
Sep 30, 2026
P/E ratio
38.00
52-wk high
$242.80
52-wk low
$160.93
EPS
$5.63
Beta
0.77
Shares outstanding
702.99M
No. of employees
59K
News stories
From web sources and news partners
AD HOC NEWS
·
19 minutes ago
Danaher stock names a new CEO ahead of the October earnings test
Simply Wall Street
·
15 hours ago
Did CEO Change Just Shift Danaher's (DHR) Investment Narrative?
StockStory
·
2 days ago
Why Danaher (DHR) Shares Are Trading Lower Today
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp